Abstract
Dermal neurofibromas are the hallmarks of neurofibromatosis type 1 (NF1). Neurofibromas harbor Schwann cells with two different genotypes: Schwann cells which carry the germline mutation and a healthy NF1 allele (NF1 +/−), and a subpopulation of Schwann cells which harbor the so-called second hit leading to inactivation of both NF1 alleles (NF1 −/−). The second hit in the NF1 gene of Schwann cells is considered to be the initial step in the development of neurofibromas. Dermal neurofibromas typically start to grow in puberty, and their number and size increase during pregnancy, indicating hormone responsiveness. This is the first study to address the effect of human chorionic gonadotropin (hCG) on the proliferation of human NF1 +/− and NF1 −/− Schwann cells in vitro. In addition, the effects of estradiol and testosterone were also investigated. The results showed that NF1 −/− Schwann cells were more sensitive to estradiol, testosterone, and human chorionic gonadotropin than NF1 +/− cells. Specifically, the proliferation of NF1 −/− Schwann cells was increased by up to 99, 110, and 170% compared to vehicle control when treated with estradiol, testosterone, and hCG, respectively. Interestingly, no effect of estradiol, testosterone, or hCG on the proliferation of the cells with NF1 +/− genotype was observed. To conclude, the somatic second hit in the NF1 gene sensitizes Schwann cells to sex hormones resulting in a highly increased proliferation. Our results highlight the significance of sex hormones in the regulation of neurofibroma growth.
Abbreviations
- NF1:
-
Neurofibromatosis type 1
- NF1 :
-
Human NF1 gene
- NF1 +/− :
-
Cells carrying the constitutional NF1 mutation only
- NF1 −/− :
-
Cells with the NF1 second hit
- NIH:
-
National Institutes of Health
- MPNST:
-
Malignant peripheral nerve sheath tumor
- hCG:
-
Human chorionic gonadotropin
- FBS:
-
Fetal bovine serum
References
Uusitalo E, Leppävirta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, Pöyhönen M, Peltonen J, Peltonen S (2015) Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol 135:904–906. https://doi.org/10.1038/jid.2014.465
Jouhilahti EM, Peltonen S, Heape AM, Peltonen J (2011) The pathoetiology of neurofibromatosis 1. Am J Pathol 178:1932–1939. https://doi.org/10.1016/j.ajpath.2010.12.056
Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004. https://doi.org/10.1038/nrdp.2017.4
Riccardi VM (1992) Neurofibromatosis: phenotype, natural history and pathogenesis. The John Hopkins University Press, Baltimore, pp 1–85
Kodra Y, Giustini S, Divona L, Porciello R, Calvieri S, Wolkenstein P, Taruscio D (2009) Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology 218:215–220. https://doi.org/10.1159/000187594
Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760–771
Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lázaro C (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 9:3055–3064
Jouhilahti EM, Peltonen S, Callens T, Jokinen E, Heape AM, Messiaen L, Peltonen J (2011) The development of cutaneous neurofibromas. Am J Pathol 178:500–505. https://doi.org/10.1016/j.ajpath.2010.10.041
Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920–922. https://doi.org/10.1126/science.1068452
Dugoff L, Sujansky E (1996) Neurofibromatosis type 1 and pregnancy. Am J Med Genet 66:7–10
Roth TM, Petty EM, Barald KF (2008) The role of steroid hormones in the NF1 phenotype: focus on pregnancy. Am J Med Genet A 146A:1624–1633. https://doi.org/10.1002/ajmg.a.32301
Posma E, Aalbers R, Kurniawan YS, van Essen AJ, Peeters PM, van Loon AJ (2003) Neurofibromatosis type I and pregnancy: a fatal attraction? Development of malignant schwannoma during pregnancy in a patient with neurofibromatosis type I. BJOG 110:530–532
Xiong M, Gilchrest BA, Obayan OK (2015) Eruptive neurofibromas in pregnancy. JAAD Case Rep 1:23–24. https://doi.org/10.1016/j.jdcr.2014.10.006
Jung-Testas I, Schumacher M, Bugnard H, Baulieu EE (1993) Stimulation of rat Schwann cell proliferation by estradiol: synergism between the estrogen and cAMP. Brain Res Dev Brain Res 72:282–290
Jung-Testas I, Schumacher M, Robel P, Baulieu EE (1996) Demonstration of progesterone receptors in rat Schwann cells. J Steroid Biochem Mol Biol 58:77–82
McLaughlin ME, Jacks T (2003) Progesterone receptor expression in neurofibromas. Cancer Res 63:752–755
Fishbein L, Zhang X, Fisher LB, Li H, Campbell-Thompson M, Yachnis A, Rubenstein A, Muir D, Wallace MR (2007) In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells. Mol Carcinog 46:512–523. https://doi.org/10.1002/mc.20236
Overdiek A, Winner U, Mayatepek E, Rosenbaum T (2008) Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone. Pediatr Res 64:40–43. https://doi.org/10.1203/PDR.0b013e31817445b8
Siriphorn A, Chompoopong S, Floyd CL (2010) 17β-estradiol protects Schwann cells against H2O2-induced cytotoxicity and increases transplanted Schwann cell survival in a cervical hemicontusion spinal cord injury model. J Neurochem 115:864–872. https://doi.org/10.1111/j.1471-4159.2010.06770.x
Chen Y, Guo W, Xu L, Li W, Cheng M, Hu Y, Xu W (2016) 17β-Estradiol promotes schwann cell proliferation and differentiation, accelerating early remyelination in a mouse peripheral nerve injury model. Biomed Res Int 2016:7891202 https://doi.org/10.1155/2016/7891202
Uusitalo E, Rantanen M, Kallionpää RA, Pöyhönen M, Leppävirta J, Ylä-Outinen H, Riccardi VM, Pukkala E, Pitkäniemi J, Peltonen S, Peltonen J (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol. https://doi.org/10.1200/JCO.2015.65.3576
Ingham S, Huson SM, Moran A, Wylie J, Leahy M, Evans DG (2011) Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years. Eur J Cancer 47:2723–2728. https://doi.org/10.1016/j.ejca.2011.05.031
Perrin GQ, Li H, Fishbein L, Thomson SA, Hwang MS, Scarborough MT, Yachnis AT, Wallace MR, Mareci TH, Muir D (2007) An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation. Lab Invest 87:1092–1102. https://doi.org/10.1038/labinvest.3700675
Li H, Zhang X, Fishbein L, Kweh F, Campbell-Thompson M, Perrin GQ, Muir D, Wallace M (2010) Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells. Cancer Biol Ther 10:758–764
O’Malley BW, Tsai MJ (1992) Molecular pathways of steroid receptor action. Biol Reprod 46:163–167
McFarland KC, Sprengel R, Phillips HS, Köhler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH (1989) Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245:494–499
Rosenbaum T, Rosenbaum C, Winner U, Müller HW, Lenard HG, Hanemann CO (2000) Long-term culture and characterization of human neurofibroma-derived Schwann cells. J Neurosci Res 61:524–532
Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L (2006) Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 27:1030–1040. https://doi.org/10.1002/humu.20389
Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D, Leppert MF, Miller JP, Moss ML, Pileggi AJ, Rapin I, Strohman RC, Swanson LW, Zimmerman A (1988) Neurofibromatosis conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578
Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514–517
Driggers PH, Segars JH (2002) Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13:422–427
Liao RS, Ma S, Miao L, Li R, Yin Y, Raj GV (2013) Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation. Transl Androl Urol 2:187–196. https://doi.org/10.3978/j.issn.2223-4683.2013.09.07
Fan HY, Shimada M, Liu Z, Cahill N, Noma N, Wu Y, Gossen J, Richards JS (2008) Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation. Development 135:2127–2137. https://doi.org/10.1242/dev.020560
DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105:608–614
Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P (2011) Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients. Dermatology 222:269–273. https://doi.org/10.1159/000327379
Lammert M, Mautner VF, Kluwe L (2005) Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients. BMC Cancer 5:16. https://doi.org/10.1186/1471-2407-5-16
Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496–2500
Welshons WV, Wolf MF, Murphy CS, Jordan VC (1988) Estrogenic activity of phenol red. Mol Cell Endocrinol 57:169–178
Seamon KB, Daly JW (1981) Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7:201–224
Acknowledgements
We would like to thank Mr. Miso Immonen for technical support. This work was supported by The Turku University Foundation and The Jalmari and Rauha Ahokas Foundation.
Data availability
Raw data is available on request.
Author information
Authors and Affiliations
Contributions
JP conceived the study. JP and SP made a significant contribution to writing the paper. SP collected the neurofibroma samples. RAK analyzed the data, drafted, and revised the paper. PP designed the experiments, cultured Schwann cells, performed the assays, analyzed the data, and wrote the paper. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This study has been performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Southwest Finland Hospital District, and patients gave their informed written consents. The study was carried out at Turku University Hospital and the University of Turku.
Rights and permissions
About this article
Cite this article
Pennanen, P., Peltonen, S., Kallionpää, R.A. et al. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/− or NF1 −/− genotype derived from human cutaneous neurofibromas. Mol Cell Biochem 444, 27–33 (2018). https://doi.org/10.1007/s11010-017-3227-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-017-3227-2